Integer (NYSE:ITGR) Given New $140.00 Price Target at Benchmark

Integer (NYSE:ITGR - Free Report) had its price objective lowered by Benchmark from $150.00 to $140.00 in a report published on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider's stock.

Several other equities research analysts also recently weighed in on ITGR. Raymond James started coverage on shares of Integer in a research note on Friday, March 28th. They issued an "outperform" rating and a $145.00 price target for the company. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. KeyCorp dropped their price target on Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research note on Monday, April 21st. Finally, Truist Financial cut their target price on Integer from $163.00 to $140.00 and set a "buy" rating on the stock in a research note on Friday, April 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $145.56.

Integer Stock Performance

Shares of NYSE:ITGR traded down $1.96 during midday trading on Friday, hitting $124.97. The company's stock had a trading volume of 163,056 shares, compared to its average volume of 345,661. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The stock's 50 day simple moving average is $118.99 and its 200 day simple moving average is $130.21. Integer has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The stock has a market capitalization of $4.36 billion, a price-to-earnings ratio of 37.19, a PEG ratio of 1.72 and a beta of 1.09.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The business had revenue of $437.39 million for the quarter, compared to analysts' expectations of $428.51 million. During the same quarter last year, the business earned $1.14 earnings per share. The firm's quarterly revenue was up 7.3% compared to the same quarter last year. As a group, research analysts anticipate that Integer will post 6.01 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. KBC Group NV boosted its holdings in shares of Integer by 83.3% in the 4th quarter. KBC Group NV now owns 1,598 shares of the medical equipment provider's stock valued at $212,000 after buying an additional 726 shares during the period. Versant Capital Management Inc raised its holdings in shares of Integer by 98.4% in the 4th quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after purchasing an additional 183 shares in the last quarter. Lord Abbett & CO. LLC raised its holdings in Integer by 3.5% during the 3rd quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock worth $37,716,000 after buying an additional 9,754 shares during the period. Tributary Capital Management LLC raised its stake in Integer by 0.8% during the 4th quarter. Tributary Capital Management LLC now owns 287,525 shares of the medical equipment provider's stock valued at $38,103,000 after purchasing an additional 2,289 shares during the period. Finally, Principal Financial Group Inc. grew its stake in Integer by 3.9% during the 4th quarter. Principal Financial Group Inc. now owns 182,267 shares of the medical equipment provider's stock valued at $24,154,000 after acquiring an additional 6,905 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.